On April 13, 2021, Advanced Proteome Therapeutics Corporation (TSXV:APC) closed the transaction. The company issued 2,559,073 units for a gross proceeds of CAD 524,610 in its final tranche. The Company paid Konkera Holdings Pty. Ltd. 319,984 12-month finders’ warrants, with each warrant exercisable into a Unit consisting of one common share and one common share purchase warrant of the Company, with each warrant exercisable until April 13, 2022. The company paid aggregate of CAD 43,040 finder's fees in the transaction. The transaction included participation from 38 placees and Total pro group involvement: 700,000 (five placees). The company has received acceptance for filing documentation from TSX Venture Exchange with respect to this transaction.